Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson's disease

Therapeutics and Clinical Risk Management

Volumn 9, Issue 1, 2013, Pages 171-176

  Sato, Yoshihiro ^a   Iwamoto, Jun ^b   Honda, Yoshiaki ^a   Amano, Nobuko ^c  

^a Mitate Hospital   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TEZUKAYAMA UNIVERSITY   (Japan)

Author keywords

Fall; Hip fracture; Parkinson's disease; Vascular parkinsonism; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ERGOCALCIFEROL;

AGED; ARTICLE; BODY MASS; BONE METABOLISM; CONTROLLED STUDY; DRUG EFFICACY; FALLING; FEMALE; GERIATRIC PATIENT; HIP FRACTURE; HUMAN; INCIDENCE; JAPAN; LEG; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PARKINSON DISEASE; PARKINSONISM; RISK REDUCTION; UNIFIED PARKINSON DISEASE RATING SCALE; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

EID: 84877904610     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S43811     Document Type: Article

References (33)

1. Aita JF. Why patients with Parkinson's disease fall. JAMA. 1982; 247(4):515-516.
2. Chiu KY, Pun WK, Luk KDK, Chow SP. Sequential fractures of both hips in elderly patients - a prospective study. J Trauma. 1992; 32(5):584-587.
3. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med. 1991;324(19):1326-1331.
4. Johnell O, Melton LG, Atkinson EJ, O'Fallon WM, Kurland LT. Fracture risk in patients with parkinsonism: a population-based study in Olmsted Country, Minnesota. Age Ageing. 1992;21(1):32-38.
5. Kao CH, Chen CC, Wang SJ, Chia LG, Yeh SH. Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry. Nucl Med Commun. 1994;15(3):173-177.
6. Taggart H, Crawford V. Reduced bone density of the hip in elderly patients with Parkinson's disease. Age Ageing. 1995;24(4):326-328.
7. Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology. 1997;49(5):1273-1278.
8. Sato Y, Kaji M, Tsuru T, Oizumi K. Risk factors for hip fracture among elderly patients with Parkinson's disease. J Neurol Sci. 2001;82(2):89-93.
9. Sato Y, Honda Y, Iwamoto J, Kanoko Y, Satoh K.Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients. Mov Disord. 2005;20(12):1598-1603.
10. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291(16):1999-2006.
11. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337(10):670-676.
12. SatoY, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis. 2005;20(3):187-192.
13. Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004;19(6):630-640.
14. Fahn S, Elton R, Members of UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent Developments in Parkinson's Disease. New York: Macmillan; 1987;2:153-163.
15. Komar L, Nieves J, Cosman F, Rubin A, Shen V, Lindsay R. Calcium homeostasis of an elderly population upon admission to a nursing home. J Am Geriatr Soc. 1993;41(10):1057-1064.
16. Medical Research Council of the United Kingdom. Aids to the Examination of the Peripheral Nervous System. London: Pendragon House; 1978.
17. Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology. 2007;68(12):911-915.
18. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;6(17):427-442.
19. Sato Y, Asoh T, Kaji M, Oizumi K. Benefical effect of intermittent cyclical etidronate thirapy in hemiplegic patients following an acute stroke. J Bone Miner Res. 2000;15(12):2487-2494.
20. Sato Y, Kanoko T, Yasuda H, Satoh K, Iwamoto J. Beneficial effect of etidronate therapy in immobilized hip fracture patients. Am J Phys Med & Rehabil. 2004;83(4):298-303.
21. Landers MR, Backlund A, Davenport J, Fortune J, Schuerman S, Altenburger P. Postural instability in idiopathic Parkinson's disease: discriminating fallers from nonfallers based on standardized clinical measures. J Neurol Phys Ther. 2008;32(2):148-149.
22. Dibble LE, Lange M. Predicting falls in individuals with Parkinson disease: a reconsideration of clinical balance measures. J Neurol Phys Ther. 2008;32(2):56-61.
23. Gallagher JC, Fowler SE, Detter JR, Sherman SS. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab. 2001;86(8):3618-3628.
24. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res. 2000;15(6):1113-1118.
25. Stein MS, Wark JD, Scherer SC, et al. Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc. 1999;47(10):1195-1201.
26. Bischoff HA, Stahelin HB, Urscheler N, et al. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil. 1999;80(1):54-58.
27. Russell JA. Osteomalacic myopathy. Muscle Nerve. 1994;17(6): 578-580.
28. Costa EM, Blau HM, Feldman D. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology. 1986;119(5):2214-2220.
29. Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev. 1986;7(4):434-447.
30. Eastwood JB, Stamp TC, De Wardener HE, Bordier PJ, Arnaud CD. The effect of 25-hydroxyvitamin D3 in the osteomalacia of chronic renal failure. Clin Sci Mol Med. 1997;52(5):499-508.
31. Stern G, Thonchin M, Smith R. Muscular weakness in metabolic bone disease. Neurology. 1973;20(6):480-483.
32. Kalra S, Grosset DJ, Benamer HT. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord. 2010;25(2):149-156.
33. Rogmark C, Carlsson A, Johnell O, Sernbo I. A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years. J Bone Joint Surg Br. 2002;84(2):183-188.